Feed ENTO
EN
Entero Therapeutics, Inc.
ENTO · NASDAQ
$2.85 -5.00% (-$0.15)
Bulios Fair Price
$182.22
6293.7% upside
Current Price
$2.85
Undervalued Fair Value Overvalued
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
50 /100
Moderate Beta 1.19x
Rev. volatility N/A
EPS volatility N/A
Ask StockBot about ENTO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jason David Sawyer
Employees
2
Headquarters
Boca Raton